As a direct result of more excellent public knowledge of colon cancer, an increasingly high percentage of individuals opt to undergo regular screenings for the condition. According to a recent survey conducted by UnitedHealth Group, the parent company of OptumCare, around half of all doctors spend little more than a few minutes with their patients discussing the many alternatives for colon cancer screening. The FIT test, which requires a sample of feces to be performed, can detect colon cancer in its early stages when therapy is likely to be more successful.
Anesthesia or sedation could be necessary for certain screenings. A collaborative effort between you and your attending physician will determine the appropriate level of sedation or anesthesia for you. Others might need to have their bowels cleansed, which is a procedure that can be rather unpleasant. In most cases, you'll need to perform the bowel edit at least a few hours before the screening. In the days leading up to the exam, you should focus on maintaining a healthy diet and drinking lots of water.
Screenings for colon cancer are vitally important because they can detect the presence of polyps in the colon long before those polyps might become cancer. Screenings can potentially prevent colorectal cancer from reaching a more advanced stage even though the risk of having the disease is relatively low. Fortunately, colon cancer can be cured if it is detected in its early stages.
Screening tests for colorectal cancer should be performed at least once every three years, beginning at 45. Screenings need to be performed much sooner on some high-risk categories of people. An increase in screenings for colorectal cancer could save millions of lives that would otherwise be lost to the disease. The disease is currently the third largest cause of death among men and women in the United States. [citation needed] On the other hand, in recent years, there has been a general downward trend in colorectal cancer among those aged 65 and older.
It has been demonstrated that colon cancer screenings increase the quality of life for cancer patients, particularly in underrepresented minority groups. The Centers for Disease Control and Prevention (CDC) reports that approximately 70 percent of Americans have annual colorectal cancer screenings; nevertheless, one in five adults aged 65 and older had not had screening as recommended. According to the CDC's projections, this may be related to a shortage of people having health insurance. In addition, several different screening tests can be utilized in conjunction with the FIT to identify cases of colon cancer.
Medicare has given its blessing to the use of the screening tool known as Cologuard, which is a stool test that reveals changed DNA in the stool. The American Cancer Society also recommends using this instrument. If the FIT test returns a positive result, further assessment is required, and this evaluation must include a diagnostic colonoscopy. However, each of these screening methods has the potential to provide false-positive findings; therefore, you must discuss all of your screening choices with your primary care physician.
The most frequent test for colon cancer is called a colonoscopy, and during this procedure, a specialized camera is used to inspect the patient's colon and rectum. This test can detect tumors and polyps, but it is also helpful in diagnosing some gastrointestinal disorders, such as Crohn's disease and ulcerative colitis. For example, this test can detect tumors and polyps.
People aged 45 and older are the target population for colon cancer screenings recommended by the American Cancer Society. However, there are risk factors that indicate that screening for colon cancer can be done earlier than that. For example, this research found a sedentary lifestyle, the use of antibiotics in childhood, and the use of food additives were associated with an increased risk of colorectal cancer in younger adults.
ความคิดเห็น